Gene · 2767
Papers2,923
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,923
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of extracellular vesicles isolated from different liquid biopsies of uveal melanoma patients. | J Circ Biomark | 2022 | 35784590 | PubTator, text mining | PubMed |
| A multi-omics deep learning model for hypoxia phenotype to predict tumor aggressiveness and prognosis in uveal melanoma for rationalized hypoxia-targeted therapy. | Comput Struct Biotechnol J | 2022 | 35782742 | PubTator, text mining | PubMed |
| The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanoma. | Cell Oncol (Dordr) | 2022 | 35781872 | PubTator, text mining | PubMed |
| Lateralized overgrowth with vascular malformation caused by a somatic PTPN11 pathogenic variant: Another piece added to the puzzle of mosaic RASopathies. | Genes Chromosomes Cancer | 2022 | 35778969 | PubTator, text mining | PubMed |
| The Youngest Infant to Be Diagnosed with Autosomal Dominant Hypocalcemia Type 2 Harboring a Novel Variant of GNA11: A Case Study and Literature Review. | Ann Clin Lab Sci | 2022 | 35777808 | PubTator, text mining | PubMed |
| Loss-of-Function Models of the Metabotropic Glutamate Receptor Genes Grm8a and Grm8b Display Distinct Behavioral Phenotypes in Zebrafish Larvae (Danio rerio). | Front Mol Neurosci | 2022 | 35769333 | PubTator, text mining | PubMed |
| A core outcome domain set for clinical research on capillary malformations (the COSCAM project): an e-Delphi process and consensus meeting. | Br J Dermatol | 2022 | 35762296 | PubTator, text mining | PubMed |
| Somatic targeted mutation profiling of colorectal cancer precursor lesions. | BMC Med Genomics | 2022 | 35761395 | PubTator, text mining | PubMed |
| Symptomatic and Stenotic Developmental Venous Anomaly with Pontine Capillary Telangiectasia: A Case Report with Genetic Considerations. | NMC Case Rep J | 2022 | 35756188 | PubTator, text mining | PubMed |
| Aphrodisiac Performance of Bioactive Compounds from Mimosa pudica Linn.: In Silico Molecular Docking and Dynamics Simulation Approach. | Molecules | 2022 | 35744923 | PubTator, text mining | PubMed |
| Stem Cell Biomarkers and Tumorigenesis in Gastric Cancer. | J Pers Med | 2022 | 35743714 | PubTator, text mining | PubMed |
| A Real-World Systematic Analysis of Driver Mutations' Prevalence in Early- and Advanced-Stage NSCLC: Implications for Targeted Therapies in the Adjuvant Setting. | Cancers (Basel) | 2022 | 35740637 | PubTator, text mining | PubMed |
| Calcium Electroporation Reduces Viability and Proliferation Capacity of Four Uveal Melanoma Cell Lines in 2D and 3D Cultures. | Cancers (Basel) | 2022 | 35740554 | PubTator, text mining | PubMed |
| Clinical and Molecular Spectrum of Sporadic Vascular Malformations: A Single-Center Study. | Biomedicines | 2022 | 35740480 | PubTator, text mining | PubMed |
| Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumors. | Int J Cancer | 2022 | 35737508 | PubTator, text mining | PubMed |
| Diagnostic Value of Microarray Method in Autism Spectrum Disorder, Intellectual Disability, and Multiple Congenital Anomalies and Some Candidate Genes for Autism: Experience of Two Centers. | Medeni Med J | 2022 | 35735171 | PubTator, text mining | PubMed |
| A case of familial hypocalciuric hypercalcemia type 1 due to CASR p.Pro55Leu mutation. | BMC Endocr Disord | 2022 | 35733207 | PubTator, text mining | PubMed |
| Clinical applications and utility of cell-free DNA-based liquid biopsy analyses in cervical cancer and its precursor lesions. | Br J Cancer | 2022 | 35725812 | PubTator, text mining | PubMed |
| Single Circulating-Tumor-Cell-Targeted Sequencing to Identify Somatic Variants in Liquid Biopsies in Non-Small-Cell Lung Cancer Patients. | Curr Issues Mol Biol | 2022 | 35723337 | PubTator, text mining | PubMed |
| Genetic Heterogeneity in Bartter Syndrome: Clinical and Practical Importance. | Front Pediatr | 2022 | 35722471 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2767/papers?page=34